UroGen Pharma
URGN
#5548
Rank
โ‚น125.67 B
Marketcap
โ‚น2,562
Share price
-12.86%
Change (1 day)
14.59%
Change (1 year)

P/S ratio for UroGen Pharma (URGN)

P/S ratio as of November 2026 (TTM): 6.06

According to UroGen Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -11.5. At the end of 2026 the company had a P/S ratio of 8.09.

P/S ratio history for UroGen Pharma from 2017 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20268.09-16.48%
20259.6892.77%
20245.02-10.27%
20235.6075.89%
20223.18-28.43%
20214.45-86.87%
202033.9-99.91%
2019> 10006197.46%
2018619929.77%
201760.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA